Showing results (101-110 of 259) with videos related to

Sort By:
Pageof 26
Neuro-Degenerative Diseases|February 4, 2012
Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoproteinDavid Holthoewer, Kristina Endres, Florian Schuck, et al.
Frontiers in Behavioral Neuroscience|September 28, 2012
Brain regions associated with the acquisition of conditioned place preference for cocaine vs. social interactionRana El Rawas, Sabine Klement, Kai K Kummer, et al.
The Journal of Clinical Psychiatry|September 5, 2014
Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluidMichael Paulzen, Sarah Groppe, Simone C Tauber, et al.
Journal of Affective Disorders|October 6, 2015
Duloxetine enters the brain - But why is it not found in the cerebrospinal fluidMichael Paulzen, Gerhard Gründer, Tanja Veselinovic, et al.
Clinical Pharmacokinetics|October 1, 2020
Elevated Clozapine Concentrations in Clozapine-Treated Patients with HypersalivationGeorgios Schoretsanitis, Maxim Kuzin, John M Kane, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 2, 2002
Schizophrenic patients who smoke have a faster finger tapping rate than non-smokersHenry Silver, Nili Shlomo, Christoph Hiemke, et al.
Psychiatry Research|December 3, 2013
Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactionsMaximilian Gahr, Roland W Freudenmann, Christoph Hiemke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 3, 2024
Therapeutic drug monitoring in Parkinson's diseaseThomas Müller, Manfred Gerlach, Gudrun Hefner, et al.
Pharmacopsychiatry|February 22, 2018
QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric InpatientsGudrun Hefner, Martina Hahn, Matthias Hohner, et al.
Pageof 26